journal article·2022-06

Multi-functional platelet membrane-camouflaged nanoparticles reduce neuronal apoptosis and regulate microglial phenotype during ischemic injury

Chaoyue Zhao, Qing Chen, Wenpan Li, Jiulong Zhang, Chunrong Yang, Dawei Chen

Publisher page

Abstract

Cerebral ischemic injury is an important factor affecting the prognosis of acute ischemic stroke (AIS). Neuronal apoptosis and the change in microglial phenotype have been implicated in the development of AIS. The changes in microglia from the M1 phenotype to the M2 phenotype could rescue neurons and reduce apoptosis. MiRNA-Let-7c reduced ischemic injury by regulating the survival of neurons and changing microglial phenotype. Here, we used the information regarding the changes in the brain microenvironment after ischemic injury and constructed pH-sensitive polymeric nanoparticles to deliver miRNA-Let-7c. The nanoparticles were coated with platelet membrane, which preserved the function of platelets while allowing nanoparticles to evade recognition by the immune system. The platelet membrane-camouflaged nanoparticles entered the neutrophils by endocytosis and used inflammatory chemotaxis of neutrophils to transport the vector across the blood–brain barrier (BBB). The platelet membrane-camouflaged nanoparticles efficiently localized to the area of the ischemic injury and delivered the miRNA-Let-7c for the targeted regulation of neurons and microglia. Based on these results, we conclude that this strategy is a favorable gene delivery system and could effectively treat ischemic injury.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · Neuroinflammation and Neurodegeneration Mechanisms · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (72)

Show source-provided references
1. Endovascular management of acute ischaemic stroke in Nepal10.1016/S2214-109X(20)30071-1 ↗
2. Encouraging an excitable brain state–Mechanisms of brain repair in stroke10.1038/s41583-020-00396-7 ↗
4. Neural stem cells transfected with reactive oxygen species-responsive polyplexes for effective treatment of ischemic stroke10.1002/adma.201807591 ↗
5. Nano-curcumin simultaneously protects the blood-brain barrier and reduces M1 microglial activation during cerebral ischemia-reperfusion injury10.1021/acsami.8b20594 ↗
6. Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound10.1038/s41467-018-04529-6 ↗
7. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment10.1021/acsnano.8b00477 ↗
8. The biphasic function of microglia in ischemic stroke10.1016/j.pneurobio.2016.01.005 ↗
9. Regulation of microglial activation in stroke10.1038/aps.2016.162 ↗
10. Microglia and ischemic stroke–A double-edged sword
11. Microglia–A unique versatile cell in the central nervous system10.1021/acschemneuro.5b00317 ↗
12. Phytochemicals as regulators of microglia/macrophages activation in cerebral ischemia10.1016/j.phrs.2021.105419 ↗
13. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke10.1038/ncomms11499 ↗
14. Neuroprotective effects of BHDPC, a novel neuroprotectant, on experimental stroke by modulating microglia polarization10.1021/acschemneuro.8b00713 ↗
15. microRNAs in cerebrovascular disease10.1007/978-3-319-22671-2_9 ↗
16. Temporally altered miRNA expression in a piglet model of hypoxic ischemic brain injury10.1007/s12035-020-02018-w ↗
17. MicroRNAs in the blood-brain barrier in hypoxic-ischemic brain injury10.2174/1570159X18666200429004242 ↗
18. δ-Opioid receptors, microRNAs, and neuroinflammation in cerebral ischemia/hypoxia10.3389/fimmu.2020.00421 ↗
19. PreImplantation factor promotes neuroprotection by targeting microRNA let-710.1073/pnas.1411674111 ↗
20. Let-7 microRNAs regulate microglial function and suppress glioma growth through toll-like receptor 710.1016/j.celrep.2019.11.029 ↗
21. Let-7 miRNAs can act through notch to regulate human gliogenesis10.1016/j.stemcr.2014.08.015 ↗
22. Upregulation of the let-7 microRNA with precocious development in lin-12/Notch hypermorphic Caenorhabditis elegans mutants10.1016/j.ydbio.2007.12.046 ↗
23. Efficient RNA drug delivery using red blood cell extracellular vesicles10.1038/s41467-018-04791-8 ↗
24. Nanoparticle biointerfacing by platelet membrane cloaking10.1038/nature15373 ↗
25. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery10.1016/j.biomaterials.2013.11.046 ↗
26. Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer10.1016/j.canlet.2015.01.011 ↗
27. Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy10.1016/j.jconrel.2020.05.016 ↗
28. Mesoporous bioactive glass for synergistic therapy of tumor and regeneration of bone tissue
29. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy10.1038/s41565-021-00950-z ↗
30. Precise and non-invasive circulating tumor cell isolation based on optical force using homologous erythrocyte binding10.1039/C9LC00361D ↗
31. 3D printing of Haversian bone–mimicking scaffolds for multicellular delivery in bone regeneration10.1126/sciadv.aaz6725 ↗
32. Tumor-associated fibroblast-targeting nanoparticles for enhancing solid tumor therapy–Progress and challenges10.1021/acs.molpharmaceut.1c00455 ↗
33. Bioinspired multifunctional biomaterials with hierarchical microstructure for wound dressing10.1016/j.actbio.2019.10.012 ↗
34. Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke10.1021/acsnano.9b08587 ↗
35. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy10.1021/acsnano.7b02533 ↗
36. Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment10.1021/acs.nanolett.1c00168 ↗
37. Platelet-neutrophil interactions under thromboinflammatory conditions10.1007/s00018-015-1845-y ↗
38. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors10.1038/s41467-021-22311-z ↗
39. Biomimetic nanoparticles for inflammation targeting10.1016/j.apsb.2017.12.002 ↗
40. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis10.1021/acsnano.6b06477 ↗
41. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization
42. Emerging approaches to functionalizing cell membrane-coated nanoparticles10.1021/acs.biochem.0c00343 ↗
43. Overcoming multidrug resistance by codelivery of MDR1-targeting siRNA and doxorubicin using EphA10-mediated pH-sensitive lipoplexes–In vitro and in vivo evaluation10.1021/acsami.8b01806 ↗
44. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA10.1016/j.biomaterials.2018.01.042 ↗
45. Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine10.1016/j.msec.2018.02.004 ↗
46. Synergistic lysosomal activatable polymeric nanoprobe encapsulating pH sensitive imidazole derivative for tumor diagnosis
47. A pH-responsive host-guest nanosystem loading succinobucol suppresses lung metastasis of breast cancer10.7150/thno.13896 ↗
48. A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting10.1039/C6NR07004C ↗
49. Dual-responsive size-shrinking nanocluster with hierarchical disassembly capability for improved tumor penetration and therapeutic efficacy10.1021/acsami.8b21580 ↗
50. T7 Peptide-functionalized PEG-PLGA micelles loaded with carmustine for targeting therapy of glioma10.1021/acsami.6b05572 ↗
51. Designing peptide nanoparticles for efficient brain delivery10.1016/j.addr.2020.10.001 ↗
52. Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle10.1021/acsami.6b01776 ↗
53. Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes10.1016/j.biomaterials.2021.120711 ↗
54. pH/Redox dual-responsive polyplex with effective endosomal escape for codelivery of siRNA and doxorubicin against drug-resistant cancer cells10.1021/acsami.9b02016 ↗
55. Platelet-camouflaged nanococktail–Simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy10.7150/thno.23654 ↗
56. Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy10.1016/j.jconrel.2020.08.030 ↗
57. Synthetic polymeric mixed micelles targeting lymph nodes trigger enhanced cellular and humoral immune responses10.1021/acsami.7b14004 ↗
58. Crosstalk between stressed brain cells–Direct and indirect effects of ischemia and aglycemia on microglia10.1186/s12974-020-1697-8 ↗
59. Autophagy and post-ischemic conditioning in retinal ischemia10.1080/15548627.2020.1767371 ↗
60. Reversible middle cerebral artery occlusion without craniectomy in rats10.1161/01.STR.20.1.84 ↗
61. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia10.1038/nm911 ↗
62. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform10.1039/C9TB02764E ↗
63. A toolbox for the longitudinal assessment of healthspan in aging mice10.1038/s41596-019-0256-1 ↗
64. Influence of vasopressin level on osmotic pressure and sodium concentration in plasma and cerebrospinal fluid in patients with intracranial lesions10.2176/nmc.29.806 ↗
65. Changes in extra-and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats10.1038/jcbfm.1986.104 ↗
66. P-selectin-deficient mice to study pathophysiology of sickle cell disease10.1182/bloodadvances.2019000603 ↗
67. Spontaneous pulmonary hypertension associated with systemic sclerosis in P-selectin glycoprotein ligand 1-deficient mice10.1002/art.41100 ↗
68. Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes10.1126/sciadv.aaz1580 ↗
69. Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified beta-Ga2O3–Cr(3+) nanoparticles10.7150/thno.33452 ↗
70. Notch signaling protects CD4 T cells from STING-mediated apoptosis during acute systemic inflammation10.1126/sciadv.abc5447 ↗
71. lncRNA CEBPA-AS1 overexpression inhibits proliferation and migration and stimulates apoptosis of OS cells via notch signaling10.1016/j.omtn.2019.10.017 ↗
72. Touchable cell biophysics property recognition platforms enable multifunctional blood smart health care10.1038/s41378-021-00329-z ↗